OPCHNasdaqServices-Home Health Care ServicesUS GAAP · USD

Option Care Health, Inc.

Option Care Health is a U.S.-based provider of home and alternate-site infusion services delivered through a national network of locations. The company supplies infusion therapies, related pharmaceuticals, nursing support, and care coordination for patients with complex and chronic medical conditions, working under physician direction across the United States.

Kysy yhtiöstä
Liikevaihto5 650milj. USD
+13,0 %v/v
Liikevoitto (EBIT)338milj. USD
+5,0 %v/v
EBIT-marginaali6,0%
−0,5 %-yks.v/v
Nettotulos208milj. USD
−2,0 %v/v
Vapaa kassavirta217milj. USD
−24,5 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

02 0004 0006 000milj. USD2020: 3 033 milj. USD2020: EBIT 111 milj. USD20202021: 3 439 milj. USD2021: EBIT 191 milj. USD20212022: 3 945 milj. USD2022: EBIT 240 milj. USD20222023: 4 302 milj. USD2023: EBIT 315 milj. USD20232024: 4 998 milj. USD2024: EBIT 322 milj. USD20242025: 5 650 milj. USD2025: EBIT 338 milj. USD20255 650338
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Infusion therapy services70 %

Administration of intravenous therapies in patients' homes or other nonhospital settings.

Pharmaceuticals and compounded solutions20 %

Medications and complex compounded products delivered as part of infusion care.

Nursing and clinical support10 %

Nursing visits, care coordination, and therapy management tied to infusion treatment.

Asiakkaat

Option Care Health serves patients needing infusion treatment for acute and chronic conditions, with care coordinated through physicians and other referral sources. Its business also depends on managed care organizations, third-party payers, hospitals, and pharmaceutical manufacturers that influence patient access, reimbursement, and therapy distribution.

Patients requiring infusion therapy

Patients receiving IV therapies at home or other nonhospital settings for chronic and acute conditions.

Managed care organizations and third-party payers

Payers that authorize, reimburse, and steer patient access to home infusion services.

Physicians and referral sources

Physicians, discharge planners, and hospital staff that refer patients into the service network.

Hospitals and health systems

Health systems that use the company for transitional and post-acute infusion care.

Pharmaceutical manufacturers

Drug makers that rely on the company for distribution, launch support, and adherence programs.

Strategia

The company’s strategy centers on expanding relationships with drug manufacturers, managed care organizations, and referral sources to secure access to new therapies and patient volume. It also uses its national footprint and clinical capabilities to support complex therapies, improve adherence, and strengthen its position in post-acute and home-based care pathways.

Maintain and expand manufacturer partnershipsLyhyt aikaväli

Access to compatible therapies and launch opportunities supports patient volume and service breadth.

Grow payer and referral network coverageKeskipitkä aikaväli

Managed care and referral relationships determine patient access and service flow.

Broaden complex therapy capabilitiesKeskipitkä aikaväli

A wider therapy mix supports relevance across chronic and acute treatment categories.

Maantiede

Option Care Health operates primarily in the United States through a national network of locations across many states. Its footprint is designed to support local patient access, payer relationships, and referral coverage, while keeping the business exposed to U.S. reimbursement, regulatory, and healthcare utilization trends.

Riskit

The business is exposed to payer reimbursement pressure, drug supply dependence, and concentration in managed care relationships, all of which can affect patient access and pricing. It also faces operational and compliance risks tied to cybersecurity, billing audits, inflation in labor and supplies, and the integration of acquisitions or strategic investments.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Payer reimbursement pressure1Dependence on compatible pharmaceuticals2Managed care concentration3Cybersecurity and privacy incidents4Billing audits and compliance reviews5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Payer reimbursement pressureVaikutus: KorkeaTodennäköisyys: Korkea

    Managed care organizations and government payers can reduce reimbursement rates or change coverage rules.

    Kohdistuu: Home infusion and specialty pharmacy reimbursement

  2. Dependence on compatible pharmaceuticalsVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The business relies on manufacturers to supply drugs that fit home infusion administration requirements.

    KohdistuuDrug supplyRecallsFDA changesManufacturer strategy
  3. Managed care concentrationVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Loss of key payer relationships could reduce patient referrals and access to covered lives.

    Kohdistuu: MCO and third-party payer contracts

  4. Cybersecurity and privacy incidentsVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The company stores protected health information and depends on secure IT systems for operations.

    KohdistuuHIPAA dataPatient recordsBilling systems
  5. Billing audits and compliance reviewsVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Government and private payer audits can lead to adverse findings, repayments, or operational changes.

    KohdistuuClaimsCodingReimbursement documentation

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition and payer estimates

Revenue is recorded at estimated net realizable amounts, so reimbursement assumptions affect reported sales and receivables.

Vaikutus: Net revenue and accounts receivable

Timing of pharmaceutical vs. nursing revenue

Drug delivery and service delivery are recognized at different points in time, affecting quarterly mix and comparability.

Vaikutus: Quarterly revenue timing

Goodwill impairment

The company carries significant goodwill from acquisitions and tests it annually for impairment.

Vaikutus: Potential non-cash impairment charges

Accounts receivable collectability

Payer mix and audit outcomes influence the collectability of billed amounts and reserve levels.

Vaikutus: Bad debt and working capital

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

HCA Healthcare, Inc.

HCA · Services-General Medical & Surgical Hospitals, NEC

P3 Health Partners Inc.

PIII · Services-Health Services

Oscar Health, Inc.

OSCR · Hospital & Medical Service Plans

National HealthCare Corporation

NHC · Services-Skilled Nursing Care Facilities

AdaptHealth Corp.

AHCO · Services-Home Health Care Services

First Choice Healthcare Solutions, Inc.

FCHS · Services-Medical Laboratories

Päivitetty: 24.9.2026